Bayer CEO: The company has shifted its business strategy to a U.S.-centric approach. We will not consider asset sales until we achieve progress in launching new drugs in the near future.

2026-04-01

Bayer CEO: The company has shifted its business strategy to a U.S.-centric approach. We will not consider asset sales until we achieve progress in launching new drugs in the near future.